These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 1361453

  • 1. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
    Triozzi PL, Eicher DM, Smoot J, Rinehart JJ.
    Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
    [Abstract] [Full Text] [Related]

  • 2. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
    Azuma A, Yagita H, Matsuda H, Okumura K, Niitani H.
    Cancer Res; 1992 Sep 15; 52(18):4890-4. PubMed ID: 1381273
    [Abstract] [Full Text] [Related]

  • 3. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
    Gwin JL, Gercel-Taylor C, Taylor DD, Eisenberg B.
    J Surg Res; 1996 Jan 15; 60(1):129-36. PubMed ID: 8592403
    [Abstract] [Full Text] [Related]

  • 4. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A.
    Eur J Immunol; 1992 Aug 15; 22(8):2047-53. PubMed ID: 1379184
    [Abstract] [Full Text] [Related]

  • 5. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K, Abe Y, Horiuchi A, Miyake M, Kimura S.
    Cell Immunol; 1995 Aug 15; 164(1):119-25. PubMed ID: 7634343
    [Abstract] [Full Text] [Related]

  • 6. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
    Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J.
    J Immunol; 1990 Nov 15; 145(10):3194-201. PubMed ID: 1700001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
    Jackson AM, Alexandrov AB, Prescott S, James K, Chisholm GD.
    Immunology; 1992 Jun 15; 76(2):286-91. PubMed ID: 1353063
    [Abstract] [Full Text] [Related]

  • 9. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA, Custer MC, Rosenberg SA, Lotze MT.
    J Biol Response Mod; 1990 Apr 15; 9(2):113-26. PubMed ID: 2111373
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
    Bendall LJ, Kortlepel K, Gottlieb DJ.
    Leukemia; 1995 Apr 15; 9(4):677-84. PubMed ID: 7723403
    [Abstract] [Full Text] [Related]

  • 12. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes.
    Symington FW, Santos EB.
    J Immunol; 1991 Apr 01; 146(7):2169-75. PubMed ID: 1672345
    [Abstract] [Full Text] [Related]

  • 13. A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-alpha, interferon-gamma and interleukin 1.
    Geissler D, Gaggl S, Möst J, Greil R, Herold M, Dietrich M.
    Eur J Immunol; 1990 Dec 01; 20(12):2591-6. PubMed ID: 1980110
    [Abstract] [Full Text] [Related]

  • 14. Interferon-gamma-induced intercellular adhesion molecule-1: expression on human tumor cells enhances bifunctional antibody-mediated lysis through a lymphocyte function-associated antigen-1 dependent mechanism.
    Ramsey PS, Dean PA, Tasimowicz-Alpini A, Donohue JH, Nelson H.
    Cancer Res; 1993 Oct 01; 53(19):4652-7. PubMed ID: 8104686
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of intercellular adhesion molecule 1 (ICAM-1) expression on the human mast-cell line (HMC)-1 by inflammatory mediators.
    Wedi B, Elsner J, Czech W, Butterfield JH, Kapp A.
    Allergy; 1996 Oct 01; 51(10):676-84. PubMed ID: 8904994
    [Abstract] [Full Text] [Related]

  • 17. Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.
    Campbell SC, Tanabe K, Alexander JP, Edinger M, Tubbs RR, Klein EA.
    J Urol; 1994 May 01; 151(5):1385-90. PubMed ID: 7908992
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
    Goedegebuure PS, Braakman E, Segal DM, Vreugdenhil RJ, Bolhuis RL.
    Int Immunol; 1990 May 01; 2(12):1213-20. PubMed ID: 1982501
    [Abstract] [Full Text] [Related]

  • 20. Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrate.
    Tada S, Saito H, Ebinuma H, Atsukawa K, Masuda T, Tsunematsu S, Morizane T, Ishii H.
    Cancer Biochem Biophys; 1996 Apr 01; 15(3):177-86. PubMed ID: 8937741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.